UNIVERSITY of PENNSYLVANIA. PATENT LICENSE AGREEMENT This Patent License Agreement (this “Agreement”) is between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Aegerion Pharmaceuticals, Inc, a Delaware corporation (“Company”). This Agreement is effective on May 19, 2006 (the “Effective Date”).
Appears in 4 contracts
Samples: Patent License Agreement (Aegerion Pharmaceuticals, Inc.), Patent License Agreement (Aegerion Pharmaceuticals, Inc.), Patent License Agreement (Aegerion Pharmaceuticals, Inc.)
UNIVERSITY of PENNSYLVANIA. PATENT LICENSE AGREEMENT This Patent License Agreement (this “Agreement”) is between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Aegerion PharmaceuticalsAAVenue Therapeutics, IncLLC, a Delaware corporation limited liability company (“Company). This Agreement is being signed on October 14, 2013 (the “Execution Date”). This Agreement is will become effective on May 19October 14, 2006 2013 (the “Effective Date”).
Appears in 2 contracts
Samples: Patent License Agreement (Spark Therapeutics, Inc.), Patent License Agreement (Spark Therapeutics, Inc.)
UNIVERSITY of PENNSYLVANIA. PATENT LICENSE AGREEMENT Patent License Agreement This Patent License Agreement (this “Agreement”) is between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Aegerion Pharmaceuticals, IncApellis AG, a Delaware corporation company organized and existing under the laws of Switzerland (“Company”). This Agreement is effective being entered into by and between Penn and Company on May 19March 28, 2006 2008 (the “Effective Date”).
Appears in 2 contracts
Samples: Stockholders Agreement (Apellis Pharmaceuticals, Inc.), Stockholders Agreement (Apellis Pharmaceuticals, Inc.)
UNIVERSITY of PENNSYLVANIA. PATENT LICENSE AGREEMENT Patent License Agreement This Patent License Agreement (this “Agreement”) is between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Aegerion PharmaceuticalsImmunoCellular Therapeutics, IncLtd., a corporation organized and existing under the laws of Delaware corporation (“Company”). This Agreement is being signed on February 10, 2012 (the “Execution Date”). This Agreement will become effective on May 19February 10, 2006 2012 (the “Effective Date”).
Appears in 1 contract
Samples: Patent License Agreement (ImmunoCellular Therapeutics, Ltd.)
UNIVERSITY of PENNSYLVANIA. PATENT LICENSE AGREEMENT Patent License Agreement This Patent License Agreement (this “Agreement”) is between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Aegerion Pharmaceuticals, IncNuPathe Inc., a Delaware corporation organized and existing under the laws of Delaware, (“Company”). This Agreement is being signed on June 21, 2006 (the “Execution Date”). This Agreement will become effective on May 19July 1, 2006 (the “Effective Date”).
Appears in 1 contract
